Small CapsResonance Health Partners with UK CRO to Include SaMD Services in Global Clinical Trials
Resonance Health signs 24-month deal with UK CRO Image Analysis to add SaMD MRI endpoints to global trials, targeting obesity and metabolic disease.
CRO
Cirralto
- Short interest
- 0.01%
- 0.00 pp 30d
- as of 4 Feb 2022
- Reported shorts
- 165.2K
- Shares on issue
- 2.935B
Cirralto (CRO) News
Latest articles and price-sensitive announcements with AI sentiment classification.
StockheadTrivarX advances MRI-based imaging platform toward phase I trial with CRO appointment
TrivarX engages specialist contract research organisation Beyond Drug Development to support preparation for a planned phase I safety trial for ... Read More The post TrivarX advances MRI-based imaging platform toward phase I trial with CRO appointment appeared first on Stockhead.